FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Guide on Blood Pressure Donor Eligibility

Federal Register notice: FDA makes available a final guidance entitled Blood Pressure and Pulse Donor Eligibility Requirements: Compliance Policy.

Medical Devices

Philips Updates Ventilator Instructions

FDA says a 4/1 Philips Respironics recall revising the use instructions for its OmniLab Advanced+ ventilator is Class 1.

latest-news-card-1
Medical Devices

Subtle Medical Imaging Software Cleared

FDA clears a Subtle Medical 510(k) for its SubtleSYNTH, which uses deep learning to generate synthetic Short Tau Inversion Recovery images from alread...

latest-news-card-1
Medical Devices

Baxter Recalls Volara System Ventilator Adapter

Baxter International recalls (Class 1) certain lots of the Volara system single-patient use circuit and blue ventilator adapter assembly due to report...

latest-news-card-1
Federal Register

Comments Extended for Guide on Platform Technology

Federal Register notice: FDA extends the comment period on its draft guidance entitled Platform Technology Designation Program for Drug Development....

latest-news-card-1
Human Drugs

FDA Opening Rare Disease Innovation Hub

CDER director Patrizia Cavazzoni and CBER director Peter Marks say they are co-leading a new FDA Rare Disease Innovation Hub.

latest-news-card-1
Biologics

Blood Donor Eligibility Compliance Policy

FDA publishes a guidance with its compliance policy about blood establishments failing to comply with some donor eligibility requirements.

latest-news-card-1
Human Drugs

Endo Recalls 1 Lot of Clonazepam

Endo recalls (Class 1) one lot of clonazepam orally disintegrating tablets 0.25 mg due to mislabeling on the cartons of some packs that shows the wron...

latest-news-card-1
Medical Devices

Hyperfine AI Swoop MR Software Cleared

FDA clears a Hyperfine 510(k) for the ninth generation of artificial intelligence-powered Swoop magnetic resonance software.

latest-news-card-1
Human Drugs

Bayer Looking to Expand Nubeqa Indication

Bayer says it will present positive results from a Phase 3 Nubeqa prostate cancer trial to FDA to consider a potential indication expansion for the dr...